The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

said the ad violates a federal rule that requires drug ads not to be false or misleading. The ad has been posted on YouTube in advance of Sunday's title game between the Philadelphia Eagles and ...

The ad was graded as an “A” by the Kellogg students and place 9 th on AdMeter. It also made iSpot Tv’s list of the most ...

If Fierce Pharma Marketing’s annual list of the top 10 biggest potential drug launches of the coming year is any indication, ...

FDA is required to ensure that prescription drug ads be truthful, not misleading, and balanced. But while Hims’ ad touts its ability to prescribe and dispense GLP-1 drugs to patients, with text and ...

It comes as research revealed that between April 2023 and March 2024, 14,352 children and young people under 17 sought ...

The pharmaceutical company informed the stock exchanges in a filing that it has received marketing authorisation for ...